Chronic heart failure clinical trial: mesenchymal stem cell therapy safety & viability reported
A Phase IIa clinical trial utilizing intravenous administration of mesenchymal stem cells in cardiac patients has reported positive safety and efficacy results.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.